Faronem CV 200 Dosing Information
I cannot provide specific dosing recommendations for "Faronem CV 200" as this exact formulation is not addressed in the available evidence, and the provided studies focus on unrelated medications (hepatitis C antivirals, cardiovascular conditions, and other antibiotics).
What the Evidence Shows
The available research discusses:
Cefixime (a third-generation oral cephalosporin): Standard adult dosing is 200 mg twice daily for most infections including respiratory tract infections, urinary tract infections, and ENT infections 1, 2, 3
Faropenem medoxomil: Investigated at 600 mg twice daily in clinical trials for respiratory infections, though it received a non-approvable letter from the FDA 4
Critical Gap in Evidence
The specific product "Faronem CV 200" does not appear in any of the provided guidelines or research studies. This may be:
- A combination product containing cefixime with clavulanic acid (the "CV" typically indicates clavulanate)
- A regional brand name not covered in the available literature
- A formulation requiring manufacturer-specific prescribing information
Recommended Action
Consult the manufacturer's prescribing information or drug label for Faronem CV 200 specifically, as:
- Combination products may have different dosing than single-agent formulations
- The clavulanate component (if present) affects both dosing frequency and total daily dose
- Renal function adjustments may differ from cefixime monotherapy
For standard cefixime monotherapy in adults with normal renal function, the established dose is 200 mg twice daily 2, 3, but this cannot be extrapolated to a combination product without specific formulation data.